Back to Journals » Clinical Interventions in Aging » Volume 14

Recovery Of Bone And Muscle Mass In Patients With Chronic Kidney Disease And Iron Overload On Hemodialysis And Taking Combined Supplementation With Curcumin And Resveratrol

Authors Murillo Ortiz BO, Fuentes Preciado AR, Ramírez Emiliano J, Martínez Garza S, Ramos Rodríguez E, de Alba Macías L.A.

Received 19 July 2019

Accepted for publication 22 October 2019

Published 18 November 2019 Volume 2019:14 Pages 2055—2062


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Richard Walker

Blanca Olivia Murillo Ortiz,1 Alma Rosa Fuentes Preciado,2 Joel Ramírez Emiliano,2 Sandra Martínez Garza,1 Edna Ramos Rodríguez,3 Luz Angélica de Alba Macías2

1Clinical Epidemiology Research Unit, UMAE No. 1 Bajio, Mexican Institute Social Security, León, Guanajuato, Mexico; 2Department of Medical Sciences, University of Guanajuato, León, Guanajuato, Mexico; 3Regional General Hospital No. 58, Mexican Institute Social Security, León, Guanajuato, Mexico

Correspondence: Blanca Olivia Murillo Ortiz
Unidad de Investigación en Epidemiología Clínica, Unidad Médica de Alta Especialidad No. 1 Bajío, Instituto Mexicano del Seguro Social, Boulevard López Mateos e Insurgentes s/n, Colonia Los Paraísos, León, Guanajuato, México
Tel/Fax +52 4777183039

Introduction: Malnutrition is common in haemodialysis patients and closely related to morbidity and mortality. We evaluated the effect of twelve weeks of supplementation with resveratrol and curcumin on recovery of bone and muscle mass and protein oxidation, lipid peroxidation on patients with chronic kidney disease and iron overload undergoing hemodialysis, we performed a randomized, double-blind, placebo-controlled trial.
Methods: We included a total of 40 patients, were randomly assigned to two groups, 20 to the group with antioxidant supplementation (Resveratrol + Curcumin) (Group A), treated with a daily oral dose of 500 mg of Resveratrol and 500 mg of Curcumin, and 20 to the control group treated with placebo (Group B).
Results: Significant differences were found in the body composition of the patients between both groups. There was a significant difference in Body Mass Index (BMI) values (p = 0.002), fat percentage (p = 0.007), muscle mass (p = 0.01) bone mass (p = 0.01), as well as in the score of the subjective global evaluation (p = 0.03). Also differences were found between the basal and final serum levels of Triglycerides (TG) (p = 0.01), VLDL (p = 0.003). A significant decrease in the levels of serum ferritin (2003.69 ± 518.73 vs 1795.65 ± 519.00 ng/mL; p = 0.04). Nor were significant differences observed between the baseline and the final Thiobarbituric Acid Reactive Substances (TBARS) values (70.45 ± 69.21 vs 50.19 ± 32.62, p = 0.24). The same results was obtained for carbonyl values (2.67 ± 0.75 vs 2.50 ± 0.85; p = 0.50).
Discussion: The present study is the first assay on patients with chronic kidney disease and iron overload that demonstrates the beneficial effects of combined supplementation with Curcumin and Resveratrol on muscle and bone mass. There was a significant decrease in circulating levels of ferritin, to finding that remarkably novel.

Keywords: curcumin, resveratrol, chronic kidney disease, recovery of bone and muscle mass

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]